Evidence based computational drug repositioning candidate screening pipeline design

Case Study

Qian Zhu, Hongfang D Liu, Yuji Zhang, Jiabei Wang

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Traditional drug development is time and cost consuming process, conversely, drug repositioning is an emerging approach to discover novel usages of existing drugs with a better risk-versus-reward trade-off. Computational technology is playing a key role in drug repositioning to screening the best drug repositioning candidates from a large candidate library. Recent efforts made for computer aided drug repositioning are mostly focusing on applying/developing data mining algorithms against wild type of large scale of biomedical data. In this paper, we introduce a novel computational pipeline designed for drug repositioning candidate screening based on existing phenotypical association (disease-disease association) discovery and pathway enrichment analysis by exploring systems biology data relevant to the interested phenotypical association specifically. To demonstrate usability and evaluate efficacy of this novel pipeline, we successfully conducted a case study by identifying potential drug repositioning candidates for Alzheimer's disease (AD) based on the studied phenotypical association between cancer and AD.

Original languageEnglish (US)
Title of host publicationInternational Conference on Systems Biology, ISB
PublisherIEEE Computer Society
Pages210-218
Number of pages9
ISBN (Print)9781479972944
DOIs
StatePublished - Dec 17 2014
Event8th International Conference on Systems Biology, ISB 2014 - Qingdao, China
Duration: Aug 24 2014Aug 27 2014

Other

Other8th International Conference on Systems Biology, ISB 2014
CountryChina
CityQingdao
Period8/24/148/27/14

Fingerprint

Drug Repositioning
Screening
Drugs
Pipelines
Pharmaceutical Preparations
Alzheimer's Disease
Alzheimer Disease
Data mining
Systems Biology
Data Mining
Reward
Libraries
Evidence
Design
Usability
Technology
Efficacy
Costs
Costs and Cost Analysis
Pathway

Keywords

  • drug repositioning
  • pathway enrichment analysis
  • phenotypical association
  • systems biology

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Computer Science Applications
  • Modeling and Simulation

Cite this

Zhu, Q., Liu, H. D., Zhang, Y., & Wang, J. (2014). Evidence based computational drug repositioning candidate screening pipeline design: Case Study. In International Conference on Systems Biology, ISB (pp. 210-218). [6990757] IEEE Computer Society. https://doi.org/10.1109/ISB.2014.6990757

Evidence based computational drug repositioning candidate screening pipeline design : Case Study. / Zhu, Qian; Liu, Hongfang D; Zhang, Yuji; Wang, Jiabei.

International Conference on Systems Biology, ISB. IEEE Computer Society, 2014. p. 210-218 6990757.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Zhu, Q, Liu, HD, Zhang, Y & Wang, J 2014, Evidence based computational drug repositioning candidate screening pipeline design: Case Study. in International Conference on Systems Biology, ISB., 6990757, IEEE Computer Society, pp. 210-218, 8th International Conference on Systems Biology, ISB 2014, Qingdao, China, 8/24/14. https://doi.org/10.1109/ISB.2014.6990757
Zhu Q, Liu HD, Zhang Y, Wang J. Evidence based computational drug repositioning candidate screening pipeline design: Case Study. In International Conference on Systems Biology, ISB. IEEE Computer Society. 2014. p. 210-218. 6990757 https://doi.org/10.1109/ISB.2014.6990757
Zhu, Qian ; Liu, Hongfang D ; Zhang, Yuji ; Wang, Jiabei. / Evidence based computational drug repositioning candidate screening pipeline design : Case Study. International Conference on Systems Biology, ISB. IEEE Computer Society, 2014. pp. 210-218
@inproceedings{57598d32bca84ba6827d193415c45f0f,
title = "Evidence based computational drug repositioning candidate screening pipeline design: Case Study",
abstract = "Traditional drug development is time and cost consuming process, conversely, drug repositioning is an emerging approach to discover novel usages of existing drugs with a better risk-versus-reward trade-off. Computational technology is playing a key role in drug repositioning to screening the best drug repositioning candidates from a large candidate library. Recent efforts made for computer aided drug repositioning are mostly focusing on applying/developing data mining algorithms against wild type of large scale of biomedical data. In this paper, we introduce a novel computational pipeline designed for drug repositioning candidate screening based on existing phenotypical association (disease-disease association) discovery and pathway enrichment analysis by exploring systems biology data relevant to the interested phenotypical association specifically. To demonstrate usability and evaluate efficacy of this novel pipeline, we successfully conducted a case study by identifying potential drug repositioning candidates for Alzheimer's disease (AD) based on the studied phenotypical association between cancer and AD.",
keywords = "drug repositioning, pathway enrichment analysis, phenotypical association, systems biology",
author = "Qian Zhu and Liu, {Hongfang D} and Yuji Zhang and Jiabei Wang",
year = "2014",
month = "12",
day = "17",
doi = "10.1109/ISB.2014.6990757",
language = "English (US)",
isbn = "9781479972944",
pages = "210--218",
booktitle = "International Conference on Systems Biology, ISB",
publisher = "IEEE Computer Society",

}

TY - GEN

T1 - Evidence based computational drug repositioning candidate screening pipeline design

T2 - Case Study

AU - Zhu, Qian

AU - Liu, Hongfang D

AU - Zhang, Yuji

AU - Wang, Jiabei

PY - 2014/12/17

Y1 - 2014/12/17

N2 - Traditional drug development is time and cost consuming process, conversely, drug repositioning is an emerging approach to discover novel usages of existing drugs with a better risk-versus-reward trade-off. Computational technology is playing a key role in drug repositioning to screening the best drug repositioning candidates from a large candidate library. Recent efforts made for computer aided drug repositioning are mostly focusing on applying/developing data mining algorithms against wild type of large scale of biomedical data. In this paper, we introduce a novel computational pipeline designed for drug repositioning candidate screening based on existing phenotypical association (disease-disease association) discovery and pathway enrichment analysis by exploring systems biology data relevant to the interested phenotypical association specifically. To demonstrate usability and evaluate efficacy of this novel pipeline, we successfully conducted a case study by identifying potential drug repositioning candidates for Alzheimer's disease (AD) based on the studied phenotypical association between cancer and AD.

AB - Traditional drug development is time and cost consuming process, conversely, drug repositioning is an emerging approach to discover novel usages of existing drugs with a better risk-versus-reward trade-off. Computational technology is playing a key role in drug repositioning to screening the best drug repositioning candidates from a large candidate library. Recent efforts made for computer aided drug repositioning are mostly focusing on applying/developing data mining algorithms against wild type of large scale of biomedical data. In this paper, we introduce a novel computational pipeline designed for drug repositioning candidate screening based on existing phenotypical association (disease-disease association) discovery and pathway enrichment analysis by exploring systems biology data relevant to the interested phenotypical association specifically. To demonstrate usability and evaluate efficacy of this novel pipeline, we successfully conducted a case study by identifying potential drug repositioning candidates for Alzheimer's disease (AD) based on the studied phenotypical association between cancer and AD.

KW - drug repositioning

KW - pathway enrichment analysis

KW - phenotypical association

KW - systems biology

UR - http://www.scopus.com/inward/record.url?scp=84920122896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920122896&partnerID=8YFLogxK

U2 - 10.1109/ISB.2014.6990757

DO - 10.1109/ISB.2014.6990757

M3 - Conference contribution

SN - 9781479972944

SP - 210

EP - 218

BT - International Conference on Systems Biology, ISB

PB - IEEE Computer Society

ER -